# AbbVie Inc. (ABBV) — Q2-2025 Earnings Results

**Report date:** 2025-07-31 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABBV/earnings/Q2-2025

## Post-Earnings Brief

### Headline

AbbVie Misses on EPS, Stock Down 0.15%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.97 | N/A | -8.39% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record, and the analysis is based solely on numerical results.

### Guidance Changes

No forward guidance data is available.

### What It Means

AbbVie's earnings report shows a miss on EPS, which may raise concerns among investors about the company's profitability. The stock reacted slightly down by 0.15%, indicating a muted response to the results. Without additional guidance or commentary from management, it remains unclear how the company plans to address these challenges moving forward.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABBV/earnings/Q2-2025_